Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4D-150 vs Aflibercept in Diabetic Macular Edema
NCT07867080Phase 3Recruiting
- Sponsor
- 4D Molecular Therapeutics
- Start
- Sep 2026
- Primary completion
- Jan 2029
- Countries
- 3
01
Overview
A Phase 3 trial of 4D-150 in diabetic macular edema (DME), sponsored by 4D Molecular Therapeutics. Started Sep 2026; status: recruiting.
02
Drugs
4D-150
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07867080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07867080.